About : Hillevax Inc
Address : 75 State Street, Boston, MA, United States, 02109
Tel : 617 213 5054
URL :
https://www.hillevax.comCode : HLVX, ISIN : US43157M1027, Exchange : NASDAQ, Country : USA
Fiscal Year End : December
IPO date : 29_Apr_2022
Employee Count : 90
HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. It develops HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company was formerly known as MokshaCo, Inc. and changed its name to HilleVax, Inc. in February 2021. HilleVax, Inc. was founded in 2019 and is headquartered in Boston, Massachusetts.